Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Metrics to compare | VM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVMPeersSector | |
---|---|---|---|---|
P/E Ratio | −13.1x | −0.6x | −0.5x | |
PEG Ratio | 0.25 | 0.00 | 0.00 | |
Price/Book | 31.3x | 0.7x | 2.6x | |
Price / LTM Sales | - | 0.7x | 3.3x | |
Upside (Analyst Target) | - | 9.2% | 42.9% | |
Fair Value Upside | Unlock | 7.5% | 6.2% | Unlock |